OMEPRAZOLE EXTENDED-RELEASE CAPSULES

The contract is a delivery order issued under the basic IDIQ contract SPE2DX-25-D-8022 by the Defense Logistics Agency, specifically for the procurement of one batch of OMEPRAZOLE EXTENDED-RELEASE CAPSULES with NSN 6505016247068 and NDC 00781-2868-92 from CARDINAL HEALTH, INC. (CAGE 00E55), at a total price of $6.58. The award was made on July 16, 2026, based on a Lowest Price Technically Acceptable approach, with no technical evaluation criteria or trade-off analysis specified, and the contractor holds certified small business, small disadvantaged business, and women-owned small business statuses. Delivery is required FOB destination on the award date, with the contractor bearing full transportation cost and risk of loss until receipt at the specified freight shipping address in North Stonington, Connecticut. The government conducts all inspection and acceptance at the destination, with strict adherence to contract specifications and no variance permitted in quantity. Packaging and shipping must occur via fastest traceable means under RDD 999/NMCS shipment protocols, explicitly prohibiting parcel post, though no formal MIL-STD or detailed packaging, preservation, or labeling specifications beyond identification numbers and NDC codes are provided. Payment will be processed electronically through EDI by DEF FIN AND ACCOUNTING SVC, BSM, using appropriation identifier 97X4930 5CBX 001 2620 S33189 and payment code SL4701. The contracting officer is Lisa Quinn with administrative support provided by Michelle Pampel of DLA Troop Support, and no COR, COTR, or PCO is designated. The NDA and unit of issue align with DLA medical supply standards, and while no formal contract clauses, attachments, or evaluation factors are listed, the terms are incorporated by reference from the underlying basic contract, reflecting a routine, high-volume, low-value pharmaceutical procurement within the Department of Defense supply chain.